pargyline has been researched along with Cancer of Lung in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, T | 1 |
| Yuan, D | 1 |
| Miao, X | 1 |
| Lv, Y | 1 |
| Zhan, P | 1 |
| Shen, X | 1 |
| Song, Y | 1 |
| Naganuma, A | 1 |
| Imura, N | 1 |
| Harrison, TS | 1 |
| Freier, DT | 1 |
| Cohen, EL | 1 |
3 other studies available for pargyline and Cancer of Lung
| Article | Year |
|---|---|
Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cel | 2012 |
[Role of metallothionein in cancer chemotherapy].
Topics: Alkynes; Animals; Antineoplastic Agents; Bismuth; Cisplatin; Drug Resistance; Female; Glycine; Lung | 1994 |
Proceedings: Recurrent pheochromocytoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adult; Child; Epinephrine; Female; Hormone | 1974 |